A Pulmonary Syndrome in Patients with Acute Myelomonocytic Leukemia and Inversion of Chromosome 16

References

• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. “Proposals for the classification of the acute leukemias. French–American–British (FAB) co-operative group”. British Journal of Haematology 1976; 33: 451–458
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. “Proposed revised criteria for the classification of acute mycloid leukemia: a report of the French–American–British Cooperative Group”. Annals of Internal Medicine 1985; 103: 620–625
   PubMed Web of Science ®Google Scholar
• Brunning R. D., Matutes E., Harris N. L., Flandrin G., Vardiman J., Bennett J., Head D. “Acute myeloid leukaemias”. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues, E. S. Jaffe, N. L. Harris, H. Stein, J. W. Vardiman. International Agency for Research on Cancer Press, Lyon 2001; 75–107
   Google Scholar
• Yunis J. J., Bloomfield C. D., Ensrud K. “All patients with acute nonlymphocytic leukemia may have a chromosomal defect”. New England Journal of Medicine 1981; 305: 135–139
   PubMed Web of Science ®Google Scholar
• Grimwade D., Walker H., Oliver F., Wheatley K., Harrison C., Harrison G., Rees J., Hann I., Stevens R., Burnett A., Goldstone A. “The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial”. Blood 1998; 92: 2322–2333
   PubMed Web of Science ®Google Scholar
• Grimwade D., Walker H., Harrison G., Oliver F., Chatters S., Harrison C. J., Wheatley K., Burnett A. K., Goldstone A. H. “The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML 11 trial”. Blood 2001; 98: 1312–1320
   PubMed Web of Science ®Google Scholar
• Nakamura H., Kuriyama K., Sadamori N., Mine M., Itoyama T., Sasagawa I., Matsumoto K., Tsuji Y., Ason N., Kageyama S. I., Sakamaki H., Emi N., Ohno R., Tomonaga M. “Morphological subtyping of acute myeloid leukemia with maturation (AML-M2): homogeneous pink-colored cytoplasm of mature neutrophils is most characteristic of AML-M2 with t(8;21)”. Leukemia 1997; 11: 651–655
   PubMed Web of Science ®Google Scholar
• Tallman M. S., Hakimian D., Shaw J. M., Lissner G. S., Russell E. J., Variakojis D. “Granulocytic sarcoma is associated with the 8:21 translocation in acute myeloid leukemia”. Journal of Clinical Oncology 1993; 11: 690–697
   PubMed Web of Science ®Google Scholar
• Byrd J. C., Weiss R. B., Arthur D. C., Lawrwncw D., Baer M. R., Davey F., Trikha E. S., Carroll J. A., Tantravahi R., Qumsiyeh M., Patil S. R., Moore J. O., Mayer R. J., Schiffer C. A., Bloomfield C. D. “Extramedulary leukemia adversely affects hematologic complete remission and overall survival in patients with t(8;21) (q22;q22): results from Cancer and Leukemia Group B 8461′'. Journal of Clinical Oncology 1997; 15: 466–475
   PubMed Web of Science ®Google Scholar
• Bloomfield C. D., Lawrence D., Byrd J. C., Carroll A., Pettenati M. J., Tantravahi R., Patil S. R., Davey F. R., Berg D. T., Schiffer C. A., Arthur D. C., Mayer R. J. “Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype”. Cancer Research 1998; 58: 4173–4179
   PubMed Web of Science ®Google Scholar
• Larson R. A., Kondo K., Vardiman J. W., Butler A. E., Golomb H. M., Rowley J. D. “Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia”. American Journal of Medicine 1984; 76: 827–841
   PubMed Web of Science ®Google Scholar
• Fenaux P., Chomienne C., Degos L. “Acute promyelocytic leukemia: Biology and treatment”. Seminars in Oncology 1997; 24: 92–102
   PubMed Web of Science ®Google Scholar
• Coco F. Lo, Nervi C., Avvisati G., Mandelli F. “Review and meeting report: acute promyelocytic leukemia: a curable disease”. Leukemia 1998; 12: 1866–1880
   PubMed Web of Science ®Google Scholar
• Sterrenberg L., Haak H. L., Brommer E. J.P., Nieuwenhuizen W. “Evidence of fibrinogen breakdown by leukocyte enzyme in a patient with acute promyelocytic leukemia”. Haemostasis 1985; 15: 126–133
   PubMedGoogle Scholar
• Imaoka S., Uede T., Shibata H., Masaoka T., Ogawa M., Sasaki Y., Iwanawa T., Terasawa T. “Fibrinolysis in patients with acute promyelocytic leukemia and disseminated intravascular coagulation during heparin therapy”. Cancer 1986; 58: 1736–1738
   PubMed Web of Science ®Google Scholar
• Tallman M. S., Kwaan H. C. “Reassessing the hemostatic disorder associated with acute promyelocytic leukemia”. Blood 1998; 79: 543–553
   Google Scholar
• Barbui T., Finazzi G., Falanga A. “The impact of alltransretinoic acid on the coagulopathy of acute promyelocytic leukemia”. Blood 1998; 91: 3093–3102
   PubMed Web of Science ®Google Scholar
• Menell J. S., Cesarman G. M., Jacovina A. T., McLaughlin M. A., Lev E. A., Hajjar K. A. “Annexin II and bleeding in acute promyelocytic leukemia”. New England Journal of Medicine 1999; 340: 994–1004
   PubMed Web of Science ®Google Scholar
• Meijers J. C., Oudijk E. J., Mosnier L. O., Bos R., Bouma B. N., Nieuwenhuis H. K., Fijnheer R. “Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukemia”. British Journal of Haematology 2000; 108: 518–523
   PubMed Web of Science ®Google Scholar
• Melnick A., Licht J. D. “Deconstructing a Disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia”. Blood 1999; 93: 3167–3215
   PubMed Web of Science ®Google Scholar
• Fenaux P., Chastang C., Chevret S., Sanz M., Dombret H., Archimbaud E., Fey M., Rayon C., Huguet F., Sotto J. J., Gardin C., Makhoul P. C., Travade P., Solary E., Fegueux N., Bordessoule D., Miguel J. S., Link H., Desablens B., Stamatoullas A., Deconinck E., Maloisel F., Castaigne S., Preudhomme C., Degos L. “A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia”. Blood 1999; 94: 1192–1200
   PubMed Web of Science ®Google Scholar
• Sanz M. A., Martin G., Rayon C., Esteve J., Gonzalez M., Diaz-Mediavilla J., Bolufer P., Barragan P., Terol M. J., Gonzalez J. D., Colomer D., Chillon C., Rivas C., Rivas T., Ribera J. M., Bornstein R., Roman J., Calasanz M. J., Arias J., Alvarez C., Ramos F., Deben G. “A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML-RAR alpha-positive acute promyelocytic leukemia. PETHEMA group”. Blood 1999; 94: 3015–3021
   PubMed Web of Science ®Google Scholar
• LeBeau M. M., Larson R. A., Bitter M. A., Vardiman J. W., Golomb H. M., Rowley J. D. “Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia: a unique cytogenetic-clinico-pathological association”. New England Journal of Medicine 1983; 309: 630–636
   PubMed Web of Science ®Google Scholar
• Liu P. P., Hajra A., Wijmenga C., Collins F. S. “Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia”. Blood 1995; 85: 2289–2302
   PubMed Web of Science ®Google Scholar
• Bettis D. R., Rohatiner A. Z.S., Evans M. L., Rassam S. M.B., Lister T. A., Gibbons B. “Abnormalities of chromosome 16q in myeloid malignancy: 14 new cases and review of the literature”. Leukemia 1992; 6: 1250–1256
   PubMed Web of Science ®Google Scholar
• Holmes R., Keating M. J., Cork A., Broach Y., Trujillo J., Dalton W. T., Jr., McCredie K. B., Freiriech E. J. “A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16) (p13q22)”. Blood 1985; 65: 1071–1078
   PubMed Web of Science ®Google Scholar
• Glass J. P., van Tassel P., Keating M. J., Cork M. A., Trujillo J., Holms R. “Central nervous system complications of a newly recognized subtype of leukemia: AMML with a pericentric inversion of chromosome 16′'. Neurology 1987; 37: 639–644
   PubMed Web of Science ®Google Scholar
• Neiman R. S., Barcos M., Berard C., Boner H., Mann R., Rydell R. E., Bennett J. M. “Granulocytic sarcoma: a clinicopathologic study of 61 biopsed cases”. Cancer 1981; 48: 1426–1437
   PubMed Web of Science ®Google Scholar
• Baer M. R., Barcos M., Farrell H., Raza A., Preisler H. D. “Acute myelogenous leukemia with leukemia cutis. Eighteen cases seen between 1969 and 1986′'. Cancer 1989; 63: 2192–2200
   PubMed Web of Science ®Google Scholar
• Eshghabadi M., Shojania A. M., Carr I. “Isolated granulocytic sarcoma: report of a case and review of the literature”. Journal of Clinical Oncology 1986; 4: 912–917
   PubMed Web of Science ®Google Scholar
• Larson R. A., Williams F., LeBau M. M., Bitter M. A., Vardiman J. W., Rowley J. D. “Acute myelomonocytc leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis”. Blood 1986; 68: 1242–1249
   PubMed Web of Science ®Google Scholar
• Marlton P., Keating M., Kantarjian H., Pierce S., O'Brian S., Freireich E. J., Estey E. “Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16′'. Leukemia 1995; 9: 965–971
   PubMed Web of Science ®Google Scholar
• Rosenow E. C., III, Wilson W. R., Cockerill F. R. “Pulmonary disease in the immunocompromised host (first of two parts)”. Mayo Clinic Proceedings 1985; 60: 473–487
   PubMed Web of Science ®Google Scholar
• Ewig S., Gkasmacher A., Ulrich B., Wilhelm K., Schafer H., Nachtsheim K. H. “Pulmonary infiltrates in neutropenic paients with acute leukemia during chemotherapy”. Chest 1998; 114: 444–451
   PubMed Web of Science ®Google Scholar
• Tenholder M. F., Hooper R. G. “Pulmonary infiltrates in leukemia”. Chest 1980; 78: 468–473
   PubMed Web of Science ®Google Scholar
• Soares F. A., Landell G. A. Magnani, de Miranda Cardoso M. C. “Pulmonary leukostasis without hyperleukocytosis: a clinicopathologic study of 16 cases”. American Journal of Hematology 1992; 40: 28–32
   PubMed Web of Science ®Google Scholar
• Kuru T., Lynch J. P. “Nonresolving or slowly resolving pneumonia”. Clinics in Chest Medicine 1999; 20: 623–651
   PubMed Web of Science ®Google Scholar
• Epler G. R., Colby T. V., McLeod T. C., Carrington C. B., Gaensler E. A. “Bronchiolitis obliterans organizing pneumonia”. New England Journal of Medicine 1985; 312: 152–158
   PubMed Web of Science ®Google Scholar
• Cordier J.-F., Loire R., Brune J. “Idiopathic bronchiolitis obliterans organizing pneumonia”. Chest 1989; 96: 999–1004
   PubMed Web of Science ®Google Scholar
• Myers T. J., Cole S. R., Klatsky A. U., Hild D. H. “Respiratory failure due to pulmonary leukostasis following chemotherapy of acute nonlymphocytic leukemia”. Cancer 1983; 51: 1808–1813
   PubMed Web of Science ®Google Scholar
• Bhatia M., Coppage L. “Dyspnea, nonproductive cough, and blasts on the peripheral smear”. Chest 1995; 107: 269–270
   PubMed Web of Science ®Google Scholar